Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Secondary acute myeloid leukemia and the role of allogeneic stem cell transplantation in a population-based setting.

Nilsson C, Hulegårdh E, Garelius H, Möllgård L, Brune M, Wahlin A, Lenhoff S, Frödin U, Remberger M, Höglund M, Juliusson G, Stockelberg D, Lehmann S.

Biol Blood Marrow Transplant. 2019 Jun 6. pii: S1083-8791(19)30363-5. doi: 10.1016/j.bbmt.2019.05.038. [Epub ahead of print]

PMID:
31176789
2.

Long-term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease.

Sadeghi B, Remberger M, Gustafsson B, Winiarski J, Moretti G, Khoein B, Klingspor L, Westgren M, Mattsson J, Ringdén O.

Biol Blood Marrow Transplant. 2019 Jun 4. pii: S1083-8791(19)30359-3. doi: 10.1016/j.bbmt.2019.05.034. [Epub ahead of print]

PMID:
31173898
3.

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.

Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hägglund H, Mattsson J, Uhlin M.

Cent Eur J Immunol. 2019;44(1):84-91. doi: 10.5114/ceji.2018.75831. Epub 2019 Apr 15.

4.

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.

Svenberg P, Wang T, Uhlin M, Watz E, Remberger M, Ringden O, Mattsson J, Uzunel M.

Clin Transplant. 2019 Mar 15:e13537. doi: 10.1111/ctr.13537. [Epub ahead of print]

PMID:
30873642
5.

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Törlén J, Gaballa A, Remberger M, Mörk LM, Sundberg B, Mattsson J, Uhlin M.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1260-1268. doi: 10.1016/j.bbmt.2019.01.029. Epub 2019 Jan 30.

6.

THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INHERITED DISEASES IS INFLUENCED BY HLA MATCH, YEAR OF TRANSPLANTATION AND IMMUNIZED FEMALE DONOR.

Ringden O, Remberger M, Gustafsson B, Moretti G, Mattsson J, Winiarski J, Sadeghi B.

Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002481. [Epub ahead of print]

PMID:
30300286
7.

Continuous Immune Cell Differentiation Inferred From Single-Cell Measurements Following Allogeneic Stem Cell Transplantation.

Chen Y, Lakshmikanth T, Olin A, Mikes J, Remberger M, Brodin P.

Front Mol Biosci. 2018 Sep 12;5:81. doi: 10.3389/fmolb.2018.00081. eCollection 2018.

8.

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation.

El-Serafi I, Remberger M, El-Serafi A, Benkessou F, Zheng W, Martell E, Ljungman P, Mattsson J, Hassan M.

Sci Rep. 2018 May 29;8(1):8293. doi: 10.1038/s41598-018-26033-z.

9.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H.

Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2.

10.

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.

Poiret T, Axelsson-Robertson R, Remberger M, Luo XH, Rao M, Nagchowdhury A, Von Landenberg A, Ernberg I, Ringden O, Maeurer M.

Front Immunol. 2018 Apr 10;9:760. doi: 10.3389/fimmu.2018.00760. eCollection 2018.

11.

Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.

Wang T, Remberger M, Axdorph Nygell U, Sundin M, Björklund A, Mattsson J, Uhlin M, Watz E.

Transfusion. 2018 Jun;58(6):1442-1451. doi: 10.1111/trf.14579. Epub 2018 Mar 13.

PMID:
29536557
12.

Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Ringden O, Baygan A, Remberger M, Gustafsson B, Winiarski J, Khoein B, Moll G, Klingspor L, Westgren M, Sadeghi B.

Stem Cells Transl Med. 2018 Apr;7(4):325-331. doi: 10.1002/sctm.17-0167. Epub 2018 Mar 13.

13.

Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.

Aronsson-Kurttila W, Baygan A, Moretti G, Remberger M, Khoein B, Moll G, Sadeghi B, Ringdén O.

Acta Haematol. 2018;139(2):106-114. doi: 10.1159/000485735. Epub 2018 Feb 7.

14.

Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis.

Swartling L, Ljungman P, Remberger M, Sundin M, Tiveljung A, Mattsson J, Sparrelid E.

Transpl Infect Dis. 2018 Apr;20(2):e12847. doi: 10.1111/tid.12847. Epub 2018 Feb 26.

PMID:
29359843
15.

Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation.

Solders M, Erkers T, Gorchs L, Poiret T, Remberger M, Magalhaes I, Kaipe H.

Front Immunol. 2017 Dec 21;8:1861. doi: 10.3389/fimmu.2017.01861. eCollection 2017.

16.

Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition.

Stikvoort A, Gaballa A, Solders M, Nederlof I, Önfelt B, Sundberg B, Remberger M, Sundin M, Mattsson J, Uhlin M.

Biol Blood Marrow Transplant. 2018 Mar;24(3):467-477. doi: 10.1016/j.bbmt.2017.11.026. Epub 2017 Nov 29.

17.

Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Ringdén O, Sadeghi B, Moretti G, Finnbogadottir S, Eriksson B, Mattsson J, Svahn BM, Remberger M.

Int J Hematol. 2018 Apr;107(4):478-485. doi: 10.1007/s12185-017-2363-5. Epub 2017 Nov 15.

PMID:
29143281
18.

Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients.

Gaballa A, Norberg A, Stikvoort A, Mattsson J, Sundberg B, Uzunel M, Remberger M, Uhlin M.

Bone Marrow Transplant. 2018 Jan;53(1):69-77. doi: 10.1038/bmt.2017.216. Epub 2017 Oct 9.

PMID:
28991250
19.

Mass Cytometry and Topological Data Analysis Reveal Immune Parameters Associated with Complications after Allogeneic Stem Cell Transplantation.

Lakshmikanth T, Olin A, Chen Y, Mikes J, Fredlund E, Remberger M, Omazic B, Brodin P.

Cell Rep. 2017 Aug 29;20(9):2238-2250. doi: 10.1016/j.celrep.2017.08.021.

20.

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.

Remberger M, Törlen J, Serafi IE, Garming-Legert K, Björklund A, Ljungman P, Sundin M, Hassan M, Mattsson J.

Int J Hematol. 2017 Oct;106(4):471-475. doi: 10.1007/s12185-017-2320-3. Epub 2017 Aug 28.

PMID:
28849374
21.

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.

Baygan A, Aronsson-Kurttila W, Moretti G, Tibert B, Dahllöf G, Klingspor L, Gustafsson B, Khoein B, Moll G, Hausmann C, Svahn BM, Westgren M, Remberger M, Sadeghi B, Ringden O.

Front Immunol. 2017 Jul 11;8:795. doi: 10.3389/fimmu.2017.00795. eCollection 2017.

22.

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Stikvoort A, Chen Y, Rådestad E, Törlén J, Lakshmikanth T, Björklund A, Mikes J, Achour A, Gertow J, Sundberg B, Remberger M, Sundin M, Mattsson J, Brodin P, Uhlin M.

Front Immunol. 2017 Jun 19;8:717. doi: 10.3389/fimmu.2017.00717. eCollection 2017.

23.

No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies.

Magalhaes I, Uhlin M, Schaffer M, Sundin M, Hauzenberger D, Remberger M, Mattsson J.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13012. Epub 2017 Jun 25.

PMID:
28510343
24.

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions.

Törlén J, Remberger M, Le Blanc K, Ljungman P, Mattsson J.

Biol Blood Marrow Transplant. 2017 Apr;23(4):677-683. doi: 10.1016/j.bbmt.2017.01.003. Epub 2017 Jan 4.

25.

High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis.

Remberger M, Afram G, Sundin M, Uhlin M, LeBlanc K, Björklund A, Mattsson J, Ljungman P.

Bone Marrow Transplant. 2016 Nov;51(11):1518-1521. doi: 10.1038/bmt.2016.159. Epub 2016 Jun 6. No abstract available.

PMID:
27272449
26.

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Törlén J, Ringdén O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, Itälä-Remes M, Remberger M, Mattsson J.

Haematologica. 2016 Nov;101(11):1417-1425. Epub 2016 Aug 4.

27.

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation.

Blennow O, Remberger M, Törlén J, Szakos A, Ljungman P, Mattsson J.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1684-1689. doi: 10.1016/j.bbmt.2016.06.008. Epub 2016 Jun 14.

28.

Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades.

Svenberg P, Remberger M, Uzunel M, Mattsson J, Gustafsson B, Fjaertoft G, Sundin M, Winiarski J, Ringdén O.

Pediatr Transplant. 2016 Aug;20(5):667-74. doi: 10.1111/petr.12723. Epub 2016 Jun 1.

PMID:
27251184
29.

Music therapy can lower the heart rates of severely sick children.

Uggla L, Bonde LO, Svahn BM, Remberger M, Wrangsjö B, Gustafsson B.

Acta Paediatr. 2016 Oct;105(10):1225-30. doi: 10.1111/apa.13452. Epub 2016 Jun 3.

PMID:
27129139
30.

Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning.

Li Q, Rane L, Poiret T, Zou J, Magalhaes I, Ahmed R, Du Z, Vudattu N, Meng Q, Gustafsson-Jernberg Å, Winiarski J, Ringdén O, Maeurer M, Remberger M, Ernberg I.

Oncotarget. 2016 May 24;7(21):30230-40. doi: 10.18632/oncotarget.8803.

31.

A first screening and risk assessment of pharmaceuticals and additives in personal care products in waste water, sludge, recipient water and sediment from Faroe Islands, Iceland and Greenland.

Huber S, Remberger M, Kaj L, Schlabach M, Jörundsdóttir HÓ, Vester J, Arnórsson M, Mortensen I, Schwartson R, Dam M.

Sci Total Environ. 2016 Aug 15;562:13-25. doi: 10.1016/j.scitotenv.2016.03.063. Epub 2016 Apr 17.

PMID:
27092417
32.

Organophosphate esters in dust samples collected from Danish homes and daycare centers.

Langer S, Fredricsson M, Weschler CJ, Bekö G, Strandberg B, Remberger M, Toftum J, Clausen G.

Chemosphere. 2016 Jul;154:559-566. doi: 10.1016/j.chemosphere.2016.04.016. Epub 2016 Apr 14.

PMID:
27085316
33.

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.

Omazic B, Remberger M, Barkholt L, Söderdahl G, Potácová Z, Wersäll P, Ericzon BG, Mattsson J, Ringdén O.

Biol Blood Marrow Transplant. 2016 Apr;22(4):676-681. doi: 10.1016/j.bbmt.2015.12.017. Epub 2015 Dec 29.

34.

HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.

Thorvaldson L, Remberger M, Winiarski J, Omazic B, Fischler B, Sundin M.

Pediatr Transplant. 2016 Feb;20(1):96-104. doi: 10.1111/petr.12623. Epub 2015 Oct 31.

PMID:
26518451
35.

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Nakasone H, Remberger M, Tian L, Brodin P, Sahaf B, Wu F, Mattsson J, Lowsky R, Negrin R, Miklos DB, Meyer E.

Haematologica. 2015 Nov;100(11):1477-85. doi: 10.3324/haematol.2015.125294. Epub 2015 Aug 6.

36.

Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.

Watz E, Remberger M, Ringden O, Ljungman P, Sundin M, Mattsson J, Uhlin M.

Transfusion. 2015 Oct;55(10):2339-50. doi: 10.1111/trf.13143. Epub 2015 May 13.

PMID:
25968813
37.

Bone marrow aspiration technique has deteriorated in recent years.

Remberger M, Ringdén O, Mattsson J.

Bone Marrow Transplant. 2015 Jul;50(7):1007-9. doi: 10.1038/bmt.2015.75. Epub 2015 Apr 20. No abstract available.

PMID:
25893451
38.

Reply to: transient grades three to four acute hepatitis is a common complication of rabbit antithymocyte globulin (thymoglobulin) administered before allogeneic stem cell transplantation.

Remberger M, Mattsson J.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1145-6. doi: 10.1016/j.bbmt.2015.03.004. Epub 2015 Mar 19. No abstract available.

39.

A broad cocktail of environmental pollutants found in eggs of three seabird species from remote colonies in Norway.

Huber S, Warner NA, Nygård T, Remberger M, Harju M, Uggerud HT, Kaj L, Hanssen L.

Environ Toxicol Chem. 2015 Jun;34(6):1296-308. doi: 10.1002/etc.2956. Epub 2015 May 5.

PMID:
25728907
40.

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Remberger M, Törlén J, Ringdén O, Engström M, Watz E, Uhlin M, Mattsson J.

Biol Blood Marrow Transplant. 2015 May;21(5):889-93. doi: 10.1016/j.bbmt.2015.01.025. Epub 2015 Feb 4.

41.

Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?

Sundin M, Remberger M, Lindqvist H, Omazic B, Sundberg B, Uzunel M, Winiarski J.

Pediatr Blood Cancer. 2015 May;62(5):890-6. doi: 10.1002/pbc.25409. Epub 2015 Jan 26.

PMID:
25623620
42.

The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients.

Legert KG, Tsilingaridis G, Remberger M, Ringdèn O, Heimdahl A, Yucel-Lindberg T, Dahllöf G.

Support Care Cancer. 2015 Jun;23(6):1749-57. doi: 10.1007/s00520-014-2538-z. Epub 2014 Nov 30.

PMID:
25433441
43.

General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.

Bergkvist K, Winterling J, Johansson E, Johansson UB, Svahn BM, Remberger M, Mattsson J, Larsen J.

Support Care Cancer. 2015 May;23(5):1273-83. doi: 10.1007/s00520-014-2476-9. Epub 2014 Oct 17.

PMID:
25322970
44.

Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation.

Hägglund H, Remberger M, Ringden O.

Bone Marrow Transplant. 2014 Dec;49(12):1541-2. doi: 10.1038/bmt.2014.184. Epub 2014 Sep 22. No abstract available.

PMID:
25243627
45.

TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.

Ahmed RK, Poiret T, Ambati A, Rane L, Remberger M, Omazic B, Vudattu NK, Winiarski J, Ernberg I, Axelsson-Robertson R, Magalhaes I, Castelli C, Ringden O, Maeurer M.

J Immunother. 2014 Oct;37(8):416-25. doi: 10.1097/CJI.0000000000000047.

PMID:
25198529
46.

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.

Poiret T, Rane L, Remberger M, Omazic B, Gustafsson-Jernberg A, Vudattu NK, Ahmed R, Ernberg I, Winiarski J, Magalhaes I, Ringden O, Maeurer M.

BMC Immunol. 2014 Jun 19;15:25. doi: 10.1186/1471-2172-15-25.

47.

Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.

Blennow O, Fjaertoft G, Winiarski J, Ljungman P, Mattsson J, Remberger M.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1646-9. doi: 10.1016/j.bbmt.2014.06.002. Epub 2014 Jun 7.

48.

Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantation.

Hansson ME, Norlin AC, Omazic B, Wikström AC, Bergman P, Winiarski J, Remberger M, Sundin M.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1537-43. doi: 10.1016/j.bbmt.2014.05.030. Epub 2014 Jun 5.

49.

Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.

Ringdén O, Remberger M, Törlén J, Engström M, Fjaertoft G, Mattsson J, Svahn BM.

Pediatr Transplant. 2014 Jun;18(4):398-404. doi: 10.1111/petr.12262.

PMID:
24802347
50.

Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.

Solders M, Martin DA, Andersson C, Remberger M, Andersson T, Ringdén O, Solders G.

Bone Marrow Transplant. 2014 Aug;49(8):1046-51. doi: 10.1038/bmt.2014.93. Epub 2014 May 5.

PMID:
24797185

Supplemental Content

Loading ...
Support Center